Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
  1. 4 Option exercise Chairman of the Board acquired 180,000 shares (option exercise)
  2. 5 Insider Annual Insider Trading Report
  3. 3/A Insider 3/A
  4. 4 Open-market sale Director sold 239,367 shares at $0.60 ($144,003)
  5. 4 Open-market sale Chief Scientific Officer sold 239,367 shares at $0.60 ($144,003)
  6. 4 Open-market sale 10% owner sold 239,367 shares at $0.60 ($144,003)
  7. 4 Open-market sale 10% owner sold 239,367 shares at $0.60 ($144,003)
  8. 4 Open-market sale Director sold 1,824,500 shares at an average $0.77 ($1,407,330)
  9. 4 Open-market sale Chief Scientific Officer sold 1,824,500 shares at an average $0.77 ($1,407,330)
  10. 4 Open-market sale 10% owner sold 1,824,500 shares at an average $0.77 ($1,407,330)
  11. 4 Open-market sale 10% owner sold 1,824,500 shares at an average $0.77 ($1,407,330)
  12. 4 Grant or award Director acquired 220,106 shares (grant or award)
  13. 4 Grant or award Chairman of the Board acquired 330,159 shares (grant or award)
  14. 4 Grant or award Director acquired 220,106 shares (grant or award)
  15. 4 Grant or award President & CEO acquired 2,616,580 shares (grant or award)
  16. 4 Grant or award CFO, Secretary, Treasurer acquired 330,159 shares (grant or award)
  17. 4 Conversion Chief Scientific Officer acquired 2,000,000 shares (conversion)
  18. 4 Grant or award Director acquired 220,106 shares (grant or award)
  19. 4 Conversion Chairman of the Board acquired 4.24 shares (conversion)
  20. 4 Conversion President & CEO acquired 100 shares (conversion)

Page 7 of 26 · 511 filings